1. Incidence and severity of HFS in colorectal cancer patients treated with capecitabine;Abushullaih;Cancer Investigation,2002
2. Capecitabine plus gemcitabine is an active combination for patients with metastatic breast cancer refractory to anthracyclines and taxanes;Andres;Proceedings of the American Society of Clinical Oncology,2003
3. Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC);Arkenau;Proceedings of the American Society of Clinical Oncology,2004
4. Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors;Asgari;Journal of Cutaneous Pathology,1999
5. Chemotherapy-induced acral erythema;Baack;Journal of the American Academy of Dermatology,1991